126 related articles for article (PubMed ID: 30969129)
1. Tumor Targeting by Peptide-Decorated Gold Nanoparticles.
Albertini B; Mathieu V; Iraci N; Van Woensel M; Schoubben A; Donnadio A; Greco SML; Ricci M; Temperini A; Blasi P; Wauthoz N
Mol Pharm; 2019 Jun; 16(6):2430-2444. PubMed ID: 30969129
[TBL] [Abstract][Full Text] [Related]
2. Tumor Chemo-Radiotherapy with Rod-Shaped and Spherical Gold Nano Probes: Shape and Active Targeting Both Matter.
Zhang L; Su H; Wang H; Li Q; Li X; Zhou C; Xu J; Chai Y; Liang X; Xiong L; Zhang C
Theranostics; 2019; 9(7):1893-1908. PubMed ID: 31037146
[TBL] [Abstract][Full Text] [Related]
3. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
4. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
5. Polymer decorated gold nanoparticles in nanomedicine conjugates.
Capek I
Adv Colloid Interface Sci; 2017 Nov; 249():386-399. PubMed ID: 28259207
[TBL] [Abstract][Full Text] [Related]
6. Polyethylene glycol-polylactic acid nanoparticles modified with cysteine-arginine-glutamic acid-lysine-alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effect.
Wu J; Zhao J; Zhang B; Qian Y; Gao H; Yu Y; Wei Y; Yang Z; Jiang X; Pang Z
Int J Nanomedicine; 2014; 9():5261-71. PubMed ID: 25419130
[TBL] [Abstract][Full Text] [Related]
7. Cyclo(RGD)-Decorated Reduction-Responsive Nanogels Mediate Targeted Chemotherapy of Integrin Overexpressing Human Glioblastoma In Vivo.
Chen W; Zou Y; Zhong Z; Haag R
Small; 2017 Feb; 13(6):. PubMed ID: 27865044
[TBL] [Abstract][Full Text] [Related]
8. Ligands for mapping alphavbeta3-integrin expression in vivo.
Schottelius M; Laufer B; Kessler H; Wester HJ
Acc Chem Res; 2009 Jul; 42(7):969-80. PubMed ID: 19489579
[TBL] [Abstract][Full Text] [Related]
9. Effects of Protein Corona on Active and Passive Targeting of Cyclic RGD Peptide-Functionalized PEGylation Nanoparticles.
Su G; Jiang H; Xu B; Yu Y; Chen X
Mol Pharm; 2018 Nov; 15(11):5019-5030. PubMed ID: 30222356
[TBL] [Abstract][Full Text] [Related]
10. Targeting B16 tumors in vivo with peptide-conjugated gold nanoparticles.
Poon W; Zhang X; Bekah D; Teodoro JG; Nadeau JL
Nanotechnology; 2015 Jul; 26(28):285101. PubMed ID: 26111959
[TBL] [Abstract][Full Text] [Related]
11. Gold Nanoparticles in Cancer Treatment.
Sztandera K; Gorzkiewicz M; Klajnert-Maculewicz B
Mol Pharm; 2019 Jan; 16(1):1-23. PubMed ID: 30452861
[TBL] [Abstract][Full Text] [Related]
12. RGD-conjugated solid lipid nanoparticles inhibit adhesion and invasion of αvβ3 integrin-overexpressing breast cancer cells.
Shan D; Li J; Cai P; Prasad P; Liu F; Rauth AM; Wu XY
Drug Deliv Transl Res; 2015 Feb; 5(1):15-26. PubMed ID: 25787336
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic nanomedicine based on dual-intelligent functionalized gold nanoparticles for cancer imaging and therapy in vivo.
Chen WH; Xu XD; Jia HZ; Lei Q; Luo GF; Cheng SX; Zhuo RX; Zhang XZ
Biomaterials; 2013 Nov; 34(34):8798-807. PubMed ID: 23932289
[TBL] [Abstract][Full Text] [Related]
14. Gold nanoparticles stabilize peptide-drug-conjugates for sustained targeted drug delivery to cancer cells.
Kalimuthu K; Lubin BC; Bazylevich A; Gellerman G; Shpilberg O; Luboshits G; Firer MA
J Nanobiotechnology; 2018 Mar; 16(1):34. PubMed ID: 29602308
[TBL] [Abstract][Full Text] [Related]
15. A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands.
Huang X; Peng X; Wang Y; Wang Y; Shin DM; El-Sayed MA; Nie S
ACS Nano; 2010 Oct; 4(10):5887-96. PubMed ID: 20863096
[TBL] [Abstract][Full Text] [Related]
16. A facile approach to functionalizing cell membrane-coated nanoparticles with neurotoxin-derived peptide for brain-targeted drug delivery.
Chai Z; Hu X; Wei X; Zhan C; Lu L; Jiang K; Su B; Ruan H; Ran D; Fang RH; Zhang L; Lu W
J Control Release; 2017 Oct; 264():102-111. PubMed ID: 28842313
[TBL] [Abstract][Full Text] [Related]
17. Tumor targeting and imaging using cyclic RGD-PEGylated gold nanoparticle probes with directly conjugated iodine-125.
Kim YH; Jeon J; Hong SH; Rhim WK; Lee YS; Youn H; Chung JK; Lee MC; Lee DS; Kang KW; Nam JM
Small; 2011 Jul; 7(14):2052-60. PubMed ID: 21688390
[TBL] [Abstract][Full Text] [Related]
18. Cell-Penetrating Peptide-Modified Gold Nanoparticles for the Delivery of Doxorubicin to Brain Metastatic Breast Cancer.
Morshed RA; Muroski ME; Dai Q; Wegscheid ML; Auffinger B; Yu D; Han Y; Zhang L; Wu M; Cheng Y; Lesniak MS
Mol Pharm; 2016 Jun; 13(6):1843-54. PubMed ID: 27169484
[TBL] [Abstract][Full Text] [Related]
19. Tumor Angiogenesis Targeted Radiosensitization Therapy Using Gold Nanoprobes Guided by MRI/SPECT Imaging.
Yang Y; Zhang L; Cai J; Li X; Cheng D; Su H; Zhang J; Liu S; Shi H; Zhang Y; Zhang C
ACS Appl Mater Interfaces; 2016 Jan; 8(3):1718-32. PubMed ID: 26731347
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Invasive Brain Tumors Using a Chain-like Nanoparticle.
Peiris PM; Abramowski A; Mcginnity J; Doolittle E; Toy R; Gopalakrishnan R; Shah S; Bauer L; Ghaghada KB; Hoimes C; Brady-Kalnay SM; Basilion JP; Griswold MA; Karathanasis E
Cancer Res; 2015 Apr; 75(7):1356-65. PubMed ID: 25627979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
